Publication | Closed Access

Phase I dose escalation and pharmacokinetic study on the nanoparticle formulation of polymeric micellar paclitaxel for injection in patients with advanced solid malignancies

NanoparticlesNanomedicineEngineeringPolymer-drug ConjugatePolymeric Micellar PaclitaxelAdvanced Solid MalignanciesMedicinePharmacologyNano-drug DeliveryPharmacotherapyTumor TargetingDrug Delivery SystemOncologyRadiation OncologyNanoparticle Formulation